Stock Groups

U.S. administers 410.2 million doses of COVID-19 vaccines

[ad_1]

© Reuters. FILE PHOTO: A healthcare worker prepares doses of the coronavirus disease (COVID-19) vaccine following Republican Governor Greg Abbott’s ban on COVID-19 vaccine mandates by any entity, including private employers, at Acres Home Multi-Service Center in Hou

(Reuters) – The United States has administered 410,189,737 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 496,915,265 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 409,438,987 vaccine doses the CDC said had gone into arms by Oct. 19 out of 495,844,635 doses delivered.

The agency said 219,381,466 people had received at least one dose while 189,709,710 people are fully vaccinated as of 6:00 a.m. ET on Wednesday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

About 11.2 million people received a booster dose of either Pfizer (NYSE:) or Moderna’s vaccine since Aug. 13, when the U.S. authorized a third dose of the vaccines for people with compromised immune systems who are likely to have weaker protection from the two-dose regimens.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



[ad_2]